BARD1 and breast cancer: Furthermore, a separate study of primary breast cancer tissues found that while BRCA1 and BARD1 predominantly colocalize in the cytoplasm, the α and β isoforms are not overexpressed in most samples, suggesting that isoform expression may not be the primary driver of BRCA1-BARD1 mislocalization in certain cancers [101].